Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -38.13% is 26% above its 5-year average of -51.60%, near the high end of its 5-year range (-2006.93%–35.91%).
9.09% below its 12-month average of -34.95%.
Reported quarterly profit margin; no daily interpolation. Q1 FY2027 (2026-06-30): -5.97%.
NET PROFIT MARGIN
-38.13%
NET PROFIT MARGIN AVG TTM
-34.95%
NET PROFIT MARGIN AVG 3Y
-9.37%
NET PROFIT MARGIN AVG 5Y
-51.60%
NET PROFIT MARGIN AVG 10Y
-90.01%
NET PROFIT MARGIN AVG 15Y
-43.63%
NET PROFIT MARGIN AVG 20Y
-30.21%
CURRENT VS TTM AVG
-9.09%
CURRENT VS 3Y AVG
-306.92%
CURRENT VS 5Y AVG
+26.10%
CURRENT VS 10Y AVG
+57.64%
CURRENT VS 15Y AVG
+12.60%
CURRENT VS 20Y AVG
-26.23%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 458 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aurora Cannabis Inc.
Market Cap
$276.26M
Net Profit Margin
-38.13%
TTM Avg
-34.95%
3Y Avg
-9.37%
5Y Avg
-51.60%
Market Cap
$275.81M
Net Profit Margin
-249.94%
TTM Avg
-1079.05%
3Y Avg
-1080.63%
5Y Avg
-787.30%
Market Cap
$283.06M
Net Profit Margin
0.00%
TTM Avg
-6.08%
3Y Avg
-1303.66%
5Y Avg
-1073.20%
Market Cap
$283.24M
Net Profit Margin
-1941.09%
TTM Avg
-1708.77%
3Y Avg
-990.85%
5Y Avg
-815.81%
Market Cap
$284.24M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$267.99M
Net Profit Margin
-8.78%
TTM Avg
-964.82%
3Y Avg
-2640.79%
5Y Avg
-1760.53%
Market Cap
$288.39M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$264.10M
Net Profit Margin
-10994.73%
TTM Avg
-520.92%
3Y Avg
-360.66%
5Y Avg
-288.77%
Market Cap
$264.07M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-5482.65%
5Y Avg
-3802.53%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurora Cannabis Inc. (ACB) | $276.26M | -38.13% | -34.95% | -9.37% | -51.60% |
| AC Immune S.A. (ACIU)vs › | $275.81M | -249.94% | -1079.05% | -1080.63% | -787.30% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $283.06M | 0.00% | -6.08% | -1303.66% | -1073.20% |
| Fate Therapeutics, Inc. (FATE)vs › | $283.24M | -1941.09% | -1708.77% | -990.85% | -815.81% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $284.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Century Therapeutics, Inc. (IPSC)vs › | $267.99M | -8.78% | -964.82% | -2640.79% | -1760.53% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $288.39M | 0.00% | 0.00% | 0.00% | 0.00% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $264.10M | -10994.73% | -520.92% | -360.66% | -288.77% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.07M | 0.00% | 0.00% | -5482.65% | -3802.53% |
| Anika Therapeutics, Inc. (ANIK)vs › | $264.05M | -3.14% | -28.33% | -34.54% | -25.62% |
Operating Margin
-14.6%
Net Profit Margin
-38.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -5.97% |
| 2026-03-31 | -149.68% |
| 2025-12-31 | 1.93% |
| 2025-09-30 | -56.96% |
| 2025-06-30 | 35.91% |
| 2025-03-31 | -27.12% |
| 2024-12-31 | 35.91% |
| 2024-09-30 | -14.84% |
| 2024-06-30 | 7.81% |
| 2024-03-31 | -25.82% |
| 2023-12-31 | -26.46% |
| 2023-09-30 | -0.83% |
| 2023-06-30 | -35.99% |
| 2023-03-31 | -129.63% |
| 2022-12-31 | -106.02% |
| 2022-09-30 | -104.75% |
| 2022-06-30 | -1231.55% |
| 2022-03-31 | -2006.93% |
| 2021-12-31 | -123.42% |
| 2021-09-30 | -19.77% |
| 2021-06-30 | -234.64% |
| 2021-03-31 | -291.19% |
| 2020-12-31 | -440.24% |
| 2020-09-30 | -150.00% |
| 2020-06-30 | -2597.14% |
| 2020-03-31 | -189.51% |
| 2019-12-31 | -2343.84% |
| 2019-09-30 | 13.33% |
| 2019-06-30 | -0.20% |
| 2019-03-31 | -243.08% |
| 2018-12-31 | -438.83% |
| 2018-09-30 | 355.40% |
| 2018-06-30 | 417.14% |
| 2018-03-31 | -119.35% |
| 2017-12-31 | 66.00% |
| 2017-09-30 | 43.16% |
| 2017-06-30 | -81.14% |
| 2017-03-31 | 2.72% |
| 2016-12-31 | -68.95% |
| 2016-09-30 | -182.77% |
| 2016-06-30 | -612.61% |
| 2016-03-31 | 1152.60% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | -158098.19% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | -43.09% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
